Krazati

Krazati Coupons & Savings Card – Discount Prices from $23788.99

Krazati (adagrasib) is a medication prescribed for the treatment of certain cancers, specifically advanced and metastatic non-small cell lung cancer (NSCLC) and colorectal cancer in adults with a specific KRAS G12C mutation. It is particularly used when prior treatments are no longer effective. For NSCLC, Krazati is taken alone, while for colorectal cancer, it is used in combination with Erbitux (cetuximab), an infusion administered weekly or biweekly. This drug functions as a KRAS G12C inhibitor. KRAS is a protein that signals cells to grow and divide. In some cancers, a KRAS G12C mutation causes uncontrolled cell growth. Krazati works by binding to the KRAS protein with this mutation, thereby inhibiting tumor growth. Krazati is conveniently available in oral tablet form, taken twice daily. However, it can cause some side effects such as diarrhea, nausea, and fatigue. Always consult with your healthcare provider to ensure this treatment is appropriate and safe for your condition.
Our Krazati coupons are free to use. You can print the coupon, email it to yourself, or receive the Krazati coupon via text message. To get your free discount, show the pharmacist your Krazati savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Krazati prices will update based on your prescription needs. Above our Krazati coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Krazati savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

200MG, Krazati (180 Tablets)

Select pharmacy

Albertsons logo

Albertsons

$23788.99

COUPON PRICE
Walmart logo

Walmart

$23900.77

COUPON PRICE
Walgreens logo

Walgreens

$23911.76

COUPON PRICE

Krazati savings card

Show this card to your pharmacist
albertsons logo

Albertsons

$23788.99

BIN

ID

PCN

GRP

019876

LHC2D5C0B9

CHIPPO

LHX

Powered by

This coupon is not insurance
Krazati (adagrasib) is a medication prescribed for the treatment of certain cancers, specifically advanced and metastatic non-small cell lung cancer (NSCLC) and colorectal cancer in adults with a specific KRAS G12C mutation. It is particularly used when prior treatments are no longer effective. For NSCLC, Krazati is taken alone, while for colorectal cancer, it is used in combination with Erbitux (cetuximab), an infusion administered weekly or biweekly. This drug functions as a KRAS G12C inhibitor. KRAS is a protein that signals cells to grow and divide. In some cancers, a KRAS G12C mutation causes uncontrolled cell growth. Krazati works by binding to the KRAS protein with this mutation, thereby inhibiting tumor growth. Krazati is conveniently available in oral tablet form, taken twice daily. However, it can cause some side effects such as diarrhea, nausea, and fatigue. Always consult with your healthcare provider to ensure this treatment is appropriate and safe for your condition.
Our Krazati coupons are free to use. You can print the coupon, email it to yourself, or receive the Krazati coupon via text message. To get your free discount, show the pharmacist your Krazati savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Krazati prices will update based on your prescription needs. Above our Krazati coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Krazati savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

Related KRAS inhibitor prescriptions

coupons from$23575.30Save -140%

More prescriptions for lung cancer

coupons from$21100.67Save 14%
coupons from$99.00Save 93%
coupons from$3417.58Save 73%
coupons from$12419.97Save 14%
coupons from$23152.62Save 14%
coupons from$38.10Save 81%
coupons from$24541.34Save 14%
coupons from$99.00Save 93%

Related KRAS inhibitor prescriptions

Lumakras Save -140%coupons from $23575.30

More prescriptions for lung cancer

Alecensa Save 14%coupons from $21100.67
Tarceva Save 93%coupons from $99.00
Xgeva Save 73%coupons from $3417.58
Gilotrif Save 14%coupons from $12419.97
Lorbrena Save 14%coupons from $23152.62
Bevacizumab Save 81%coupons from $38.10
Xalkori Save 14%coupons from $24541.34
Erlotinib Save 93%coupons from $99.00

Price history for Krazati

180 Tablets, 200MG

Average retail price for Krazati

Average SaveHealth price for Krazati

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Krazati dosage forms

Use our Krazati 200MG coupon with prices from $23788.99 for 180 Tablets.
DosageQuantityPrice fromPer unit
200MG180 Tablets$23788.99$132.16
Show more dosage forms >
Krazati FAQs
Is Krazati chemotherapy or immunotherapy?

Krazati is not classified as chemotherapy or immunotherapy. It is a targeted therapy, specifically a KRAS G12C inhibitor, used in the treatment of certain types of cancer.

Krazati is used for the treatment of non-small cell lung cancer (NSCLC) in patients who have a specific mutation in the KRAS G12C gene. It is typically prescribed when the cancer has spread to other parts of the body or cannot be surgically removed, and after the patient has received at least one prior systemic therapy.

Krazati, also known as adagrasib, is a medication that has shown the ability to shrink tumors in certain patients with specific types of cancer. It is particularly used in cases where tumors have a KRAS G12C mutation. The effectiveness of Krazati in shrinking tumors can vary depending on individual patient factors and the specific characteristics of the cancer. It is important for patients to discuss treatment options and potential outcomes with their healthcare provider.

Krazati is not classified as chemotherapy. It is a targeted therapy medication used to treat certain types of cancer by specifically inhibiting the KRAS G12C mutation.

The cost of Krazati can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs that could help reduce the cost.

Related Drugs